Please contact Sales at: (212) 520-2765 or email [email protected]
Latest From Lpath, Inc.
Now more than ever, surgeons have the option to pick which robot they wish to use in surgery. Picking apart the reasons why reveals much similarity between the two surgical disciplines.
Newcomers to the market have increased the number of options available to both soft tissue and orthopedic surgeons when selecting a robot. Despite the two disciplines' differences, the factors considered by surgeons when picking a system are relatively similar.
Cash is available for start-up, growth-stage and public companies through Texas Medical Center’s newly doubled venture fund, a pandemic preparedness initiative and new VC funds. In recent financings, Nutcracker closed a $167m series C round and 2Seventy raised $170m in a private placement.
Not all of the key medtech deals of 2016 were blockbusters. Herein are some of the more interesting smaller deals of the year.
- In Vitro Diagnostics
- Drug Discovery Tools
- Other Names / Subsidiaries
- Lpath Therapeutics Inc.
- Neighborhood Connections, Inc.
All set! This article has been sent to email@example.com.
All fields are required. For multiple recipients, separate email addresses with a semicolon.